98%
921
2 minutes
20
Background: Poor prognosis brings great physical suffering and financial burden to patients with renal cell carcinoma (RCC) after nephrectomy. This study aims to explore the application of machine learning for feature selection in predicting survivability and construct a well-performed prognostic model for identifying and managing the high-risk patients.
Methods: We retrospectively analyzed 737 patients with RCC after nephrectomy. Important features were respectively selected by least absolute shrinkage and selection operator (LASSO) regression and random survival forest (RSF), and the LASSO-Cox model and RSF-Cox model were constructed in conjunction with Cox regression. And their predictive performance were evaluated and compared by the C-index, calibration curve, decision curve analysis (DCA), area under the curve (AUC) of the receiver operating characteristic (ROC), and Kaplan-Meier curve. Besides, a Cox model was constructed using all clinical variables and compared with the C-index and AUC of the two models described above to demonstrate the necessity of feature selection.
Results: A total of 725 cases fitted this study ultimately, of which 48 died during the period of follow-up. The shared variables for the two models were tumor size, preoperative plasma fibrinogen content, N stage, and Fuhrman grade. In the training set, the C-index of the Cox, LASSO-Cox and RSF-Cox was 0.863, 0.893 and 0.874, and the 5-year AUC was 0.816, 0.880 and 0.837. And in the validation set, the C-index was 0.837, 0.856 and 0.821, and the 5-year AUC was 0.790, 0.855 and 0.852. The calibration and DCA curves suggested that the LASSO-Cox model outperformed the RSF-Cox model in survival prediction and net benefit. Significant survival differences were observed between the low and high-risk groups.
Conclusions: The LASSO-Cox model we constructed has been simplified and obtained higher efficiency, which can help to inform early intervention and clinical decision-making.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.21037/cco-24-137 | DOI Listing |
Front Immunol
September 2025
Department of Clinical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People's Hospital, Guigang, Guangxi, China.
Background: Hepatocellular carcinoma (HCC) prognosis continues to be challenging due to tumor heterogeneity and dynamic immunosuppressive microenvironments. Although pyroptosis plays a critical role in tumor-immune interactions, its prognostic significance in HCC at single-cell resolution has not been systematically investigated.
Methods: We analyzed a publicly available single-cell RNA sequencing (scRNA-seq) data from 10 HCC tumors and paired adjacent tissue samples (60,496 cells) to elucidate pyroptosis-related gene (PRG) profiles.
Nan Fang Yi Ke Da Xue Xue Bao
August 2025
Department of Urology, Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China.
Objectives: To identify immunosuppressive neutrophil subsets in patients with prostate cancer (PCa) and construct a risk prediction model for prognosis and immunotherapy response of the patients based on these neutrophil subsets.
Methods: Single-cell and transcriptome data from PCa patients were collected from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). Neutrophil subsets in PCa were identified through unsupervised clustering, and their biological functions and effects on immune regulation were analyzed by functional enrichment, cell interaction, and pseudo-time series analyses.
Ann Surg Oncol
September 2025
Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
Background: Accurate prognostic prediction is crucial for personalized treatment of patients with lung adenocarcinoma (LUAD) receiving epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study aims to develop and validate a pathomics-based prognostic model for EGFR-TKI-treated patients with LUAD.
Patients And Methods: Data from 122 patients with LUAD who underwent first-line EGFR-TKI therapy were retrospectively analyzed.
Biology (Basel)
August 2025
Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
The overall survival of hepatocellular carcinoma (HCC) remains poor, highlighting the need for better prognostic tools. Nucleotide metabolism fuels tumor progression, while the immune microenvironment dictates therapy response, but integrated models combining both features are lacking. Using TCGA-LIHC transcriptomic/clinical data, we identified nucleotide metabolism and immune-related differentially expressed genes (NMIRGs), which stratified HCC patients into two subtypes via non-negative matrix factorization.
View Article and Find Full Text PDFConnect Tissue Res
September 2025
Department of Orthopedics, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan Province, P. R. China.
Objective: Osteosarcoma, mainly arising from mesenchymal cells, is the most common bone tumor in children and adolescents, with high malignancy and a tendency for metastasis and recurrence. Epithelial cells undergoing epithelial-mesenchymal transition (EMT) often signal the start of tumor metastasis, as they gain mesenchymal characteristics that enhance their migration and invasion capabilities.
Methods: Osteosarcoma patient gene expression and clinical data were retrieved from the TARGET database.